
After four months and several failed bids Astellas Pharma has signed a definitive merger agreement with US biotech firm OSI …

A new takeover bid launched by Japanese pharma company Astellas for OSI Pharma has been rejected by the company’s board. …

Astellas has launched a hostile takeover bid for OSI Pharmaceuticals, going directly to stockholders with a proposal that values the US …
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer

